Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benharroch

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|May 29, 2003
New candidate virus in association with Hodgkin's diseaseD Benharroch, Y Shemer-Avni, A Levy, et al.
Scientific Reports|March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney diseaseDaniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles VirusHila Winer, Janet Ozer, Yonat Shemer, et al.
International Journal of Cancer|April 10, 1997
Association of the Epstein-Barr virus with Hodgkin's disease in Southern IsraelD Benharroch, P Brousset, J Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesisElena Voronov, Dror S Shouval, Yakov Krelin, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
Journal of the National Cancer Institute|February 7, 2001
Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in IsraelB Davidovici, I Karakis, D Bourboulia, et al.
Immunology Letters|December 1, 1993
Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicityR N Apte, A Douvdevani, M Zoller, et al.
The Journal of Investigative Dermatology|November 2, 2007
Expression of ligands to NKp46 in benign and malignant melanocytesEmanuela Cagnano, Oren Hershkovitz, Alon Zilka, et al.
International Journal of Molecular Sciences|May 13, 2023
In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i> on Cells and K18-<i>hACE2</i> Mice Infected with SARS-CoV-2Shay Weiss, Kamran Waidha, Saravanakumar Rajendran, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|May 29, 2003
New candidate virus in association with Hodgkin's diseaseD Benharroch, Y Shemer-Avni, A Levy, et al.
Scientific Reports|March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney diseaseDaniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles VirusHila Winer, Janet Ozer, Yonat Shemer, et al.
International Journal of Cancer|April 10, 1997
Association of the Epstein-Barr virus with Hodgkin's disease in Southern IsraelD Benharroch, P Brousset, J Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesisElena Voronov, Dror S Shouval, Yakov Krelin, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
Journal of the National Cancer Institute|February 7, 2001
Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in IsraelB Davidovici, I Karakis, D Bourboulia, et al.
Immunology Letters|December 1, 1993
Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicityR N Apte, A Douvdevani, M Zoller, et al.
The Journal of Investigative Dermatology|November 2, 2007
Expression of ligands to NKp46 in benign and malignant melanocytesEmanuela Cagnano, Oren Hershkovitz, Alon Zilka, et al.
International Journal of Molecular Sciences|May 13, 2023
In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i> on Cells and K18-<i>hACE2</i> Mice Infected with SARS-CoV-2Shay Weiss, Kamran Waidha, Saravanakumar Rajendran, et al.
Pageof 15